Health Care

Can Jubilant Pharmova leverage their position?

● Apr 5, 2023

“In FY24, Company’s profitability is expected to improve, driven by growth in Radiopharmaceuticals, Allergy Immunotherapy and CDMO Sterile Injectables businesses....

Glenmark Pharmaceuticals: An Uphill Battle

● Mar 23, 2023

“Strategic priority is to enhance our free cash generation and further debt reduction and we continue discussion with potential partners...

Neuland Laboratories Limited Q3 FY23 Earnings Conference Call Insights

● Mar 10, 2023

Key highlights from Neuland Laboratories Limited (NEULANDLAB) Q3 FY23 Earnings Concall Management Update: [00:05:35] NEULANDLAB said its raw material prices...

Sequent Scientific Limited Q3 FY23 Earnings Conference Call Insights

● Mar 9, 2023

Key highlights from Sequent Scientific Limited (SEQUENT) Q3 FY23 Earnings Concall Management Update: [00:05:37] SEQUENT said that in the API...

Supriya Lifescience Ltd Q3 FY23 Earnings Conference Call Insights

● Mar 9, 2023

Key highlights from Supriya Lifescience Ltd (SUPRIYA) Q3 FY23 Earnings Concall Management Update: [00:04:00] SUPRIYA said its primary focus remains...

The Revival of Amrutanjan Healthcare Limited

● Mar 7, 2023

Amrutanjan’s flagship yellow headache balm is possibly its most successful product. It is also among the first products that the...

Orchid Pharma Ltd Q3 FY23 Earnings Conference Call Insights

● Mar 6, 2023

Key highlights from Orchid Pharma Ltd (ORCHPHARMA) Q3 FY23 Earnings Concall Q&A Highlights: [00:04:43] Himanshu Upadhyay from o3 Capital asked...

Apollo Hospitals Enterprise Limited Q3 FY23 Earnings Conference Call Insights

● Mar 3, 2023

Key highlights from Apollo Hospitals Enterprise Limited (APOLLOHOSP) Q3 FY23 Earnings Concall Management Update: [00:02:04] APOLLOHOSP said it had a...

Sun Pharma Advanced Research Q3FY23 Earnings

● Mar 1, 2023

(SPARC) Sun Pharma Advanced Research Company Limited conducts pharmaceutical product research and development (R&D). Financial Results: After nine consecutive quarters...

Earnings | Dr Lal Path Labs Ltd (NSE:LALPATHLAB): Q3FY23 Results Out; Total Income fell 2% YoY

● Feb 28, 2023

Dr Lal Path Labs Ltd (NSE:LALPATHLAB) is a leading diagnostic services provider in India. The company was founded in 1949...